Alterity Therapeutics Receives a $4.74 million Research & Development Tax Incentive Refund August 15, 2023August 15, 2023
Metal Hypothesis for Alzheimer’s, Huntington and other Neurodegenerative Diseases Declared Promising Therapeutic Strategy by Scientists at New York Academy of Sciences Symposium July 17, 2013August 16, 2022